NFIB and small cell lung carcinoma: We have shown that arginine methylation of NFIB is important for the progression of small cell lung cancer (Figs. 3 and 4), and elimination of this methylation either by removal of CARM1 or by mutation of the NFIB methylation site, significantly prolongs the survival of the SCLC mouse model (Fig. 3).